Article By:
Benzinga
Sunday, October 11, 2020 2:26 PM EDT
Biotech stocks advanced along with the market in the past week, though the news flow was light. Antibody treatment for COVID-19 took the spotlight, with both Eli Lilly And Co and Regeneron Pharmaceuticals Inc requesting emergency use authorizations.
